<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1641204</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: circDENND4C serves as a sponge for miR-200b to drive non-small cell lung cancer advancement by regulating MMP-9 expression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lv</surname>
<given-names>Yaming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Lan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yunhui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2100896/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wei</surname>
<given-names>Dong</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hu</surname>
<given-names>Yajie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2754452/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Respiratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology</institution>, <addr-line>Kunming</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Respiratory Medicine, The First People&#x2019;s Hospital of Yunnan Province</institution>, <addr-line>Kunming</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Kunming</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and reviewed by: Cecilia Ana Suarez, National Scientific and Technical Research Council (CONICET), Argentina</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Dong Wei, <email xlink:href="mailto:mdhiweidong@sina.com">mdhiweidong@sina.com</email>; Yajie Hu, <email xlink:href="mailto:huyajie880217@163.com">huyajie880217@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1641204</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Lv, Wang, Zhang, Wei and Hu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Lv, Wang, Zhang, Wei and Hu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front Oncol" journal-id-type="nlm-ta" xlink:href="10.3389/fonc.2025.1441384" ext-link-type="doi">A Correction on <article-title>circDENND4C serves as a sponge for miR-200b to drive non-small cell lung cancer advancement by regulating MMP-9 expression</article-title> By Lv Y, Wang L, Zhang Y, Wei D and Hu Y (2025) <italic>Front. Oncol.</italic>&#xa0;15:1441384. doi:&#xa0;<object-id>10.3389/fonc.2025.1441384</object-id>
</related-article>
<kwd-group>
<kwd>circDENND4C</kwd>
<kwd>miR-200b</kwd>
<kwd>MMP-9</kwd>
<kwd>non-small cell lung cancer (NSCLC)</kwd>
<kwd>tumor progression</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="522"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Thoracic Oncology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>There was a mistake in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref> as published. In <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, due to the author&#x2019;s unintentionally arranged error, the flow cytometry image of apoptosis results of the miR-200b-Knockdown group was incorrected as the image of the Mock group. In <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>, due to the author adopted the same photoing techniques to obtain many high quality pictures for the migration and invasion experiments, the original picture sources of the Plasmid-Control group and the miR-200b-Over group were unintentionally misused when the author selected the photos and arranged them. The corrected [<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>] and its caption &#x201c;<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref> Flow cytometry was used to analyze the apoptotic rate of A549 cells transfected with the overexpression and knockdown vectors of circDENN4C, miR-200b and MMP-9. The data are presented as the mean &#xb1; SEM.&#x201d; and &#x201c;<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref> The invasion of A549 cells transfected with the indicated vectors was assessed by transwell invasion assay. The data are presented as the mean &#xb1; SEM.&#x201d; appear below.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Influences of the circDENND4C/miR-200b/MMP-9 regulatory axis on cell cycle and cell death of A549 cells. <bold>(A)</bold> Flow cytometry was used to analyze the cell cycle in A549 cells transfected with the overexpression and knockdown vectors of circDENN4C, miR-200b, and MMP-9. <bold>(B)</bold> Flow cytometry was used to analyze the apoptotic rate of A549 cells transfected with the overexpression and knockdown vectors of circDENN4C, miR-200b and MMP-9.The data are presented as the mean &#xb1; SEM. The <italic>p</italic>-values at the bottom of the bar chart are obtained by ANOVA among multiple groups, while the NS and detailed <italic>p</italic>-values labeled in the bar chart are the results of post-ANOVA comparison. NS, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1641204-g005.tif">
<alt-text content-type="machine-generated">Charts showing cell cycle progression and cell death under various conditions. Part A depicts cell proliferation with flow cytometry plots and a bar graph comparing G1, S, and G2 phase percentages. Part B displays total cell death with scatter plots and a bar chart illustrating early apoptosis, late apoptosis, and necrosis rates. Statistical significance between different treatments is indicated, with some showing &#x201c;NS&#x201d; for not significant.</alt-text>
</graphic>
</fig>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>The circDENND4C/miR-200b/MMP-9 axis regulated NSCLC cell migration and invasion. <bold>(A)</bold> The migration of A549 cells transfected with the indicated vectors was assessed by the transwell migration assay. <bold>(B)</bold> The invasion of A549 cells transfected with the indicated vectors was assessed by transwell invasion assay. The data are presented as the mean &#xb1; SEM. The <italic>p</italic>-values on the right side of the bar chart are obtained by ANOVA among multiple groups, while the detailed <italic>p</italic>-values labeled in the bar chart are the results of post-ANOVA comparison. NS, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1641204-g006.tif">
<alt-text content-type="machine-generated">Microscopy images and bar charts show cell migration and invasion under different conditions. Images A and B depict various treatments: Mock, Plasmid-Control, circDENN4C-Over, circDENN4C-Knockdown, miR-200b-Over, miR-200b-Knockdown, MMP-9-Over, and si-MMP-9. Bar charts compare the number of migratory and invasive cells with statistical significance marked by P-values.</alt-text>
</graphic>
</fig>
<p>The original article has been updated.</p>
</body>
<back>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>